Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-16-017878
Filing Date
2016-06-07
Accepted
2016-06-07 16:43:53
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1701379
2 GRAPHIC g142578g04e65.jpg GRAPHIC 135419
3 GRAPHIC g142578g06l57.jpg GRAPHIC 173371
4 GRAPHIC g142578g10y51.jpg GRAPHIC 99928
5 GRAPHIC g142578g15c64.jpg GRAPHIC 44883
6 GRAPHIC g142578g20t64.jpg GRAPHIC 134650
7 GRAPHIC g142578g21p99.jpg GRAPHIC 91078
8 GRAPHIC g142578g21v14.jpg GRAPHIC 82516
9 GRAPHIC g142578g30w28.jpg GRAPHIC 71161
10 GRAPHIC g142578g33i13.jpg GRAPHIC 45201
11 GRAPHIC g142578g45h39.jpg GRAPHIC 41979
12 GRAPHIC g142578g49x55.jpg GRAPHIC 151200
13 GRAPHIC g142578g58g66.jpg GRAPHIC 78788
14 GRAPHIC g142578g58m29.jpg GRAPHIC 59459
15 GRAPHIC g142578g61v53.jpg GRAPHIC 44621
16 GRAPHIC g142578g87e13.jpg GRAPHIC 44888
17 GRAPHIC g142578g89t23.jpg GRAPHIC 44196
18 GRAPHIC g142578g97l59.jpg GRAPHIC 34352
  Complete submission text file 0000950123-16-017878.txt   3591442
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01276 | Film No.: 161701744
SIC: 2834 Pharmaceutical Preparations